Cronos Group (TSE:CRON)
TSX:CRON
Earnings Data
Report Date
May 12, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
<0.01Last Year’s EPS
0.03Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed a largely positive tone driven by record annual and quarterly results, strong organic revenue growth (25% full year; Q4 +47%), product and brand momentum in Canada (Spinach, edibles, vapes) and robust international performance (Israel +52%, other international +68%). The company emphasized a strong balance sheet (no debt, $832M cash), disciplined capital allocation (share repurchases, modest CapEx) and strategic expansion via the accretive CanAdelaar acquisition. Near-term operational challenges tied to GrowCo expansion caused Q4 margin and adjusted EBITDA pressures as well as some shipment timing effects, but management expects these to normalize and views full-year 2025 margins (43%) as a reasonable run rate. Overall, highlights meaningfully outweigh the lowlights, with manageable operational issues and clear levers for margin recovery and growth.Company Guidance
Record Annual and Quarterly Results
Delivered a record year in 2025 with organic net revenue growth of 25% year-over-year; achieved record net revenue in Q4 and for the full year, and record full year gross profit and adjusted EBITDA.
Strong Q4 Revenue Beat
Consolidated Q4 net revenue of $44.5 million, up 47% year-over-year, driven by higher cannabis flower sales in Israel, Canada and other countries and higher cannabis extract sales in Canada.
Improved Gross Profit and Margins
Q4 gross profit was $16.2 million with a 36% adjusted gross margin, a 670 basis point improvement versus 30% adjusted gross margin in Q4 2024; full year 2025 adjusted gross margin was 43% (company views this as a reasonable go-forward level).
Adjusted EBITDA Recovery
Adjusted EBITDA in Q4 was $0.5 million, an improvement of $7.7 million year-over-year, contributing to record full-year adjusted EBITDA.
Canada Market Momentum and Product Leadership
Canada net revenue up 42% year-over-year in Q4. Spinach brand notable: became #2 overall vape brand in Canada in December (up from #4 in Q1 2025); Spinach achieved #1 market share in vape cartridges in Q4, with Cherry Crush and Blueberry Dynamite the top two vape cartridge SKUs nationwide.
Edibles and SKU Success
Sour edibles approached ~22% category share in the quarter; 'fully blasted' multipacks launched mid-2025 produced 4 of the top 10 edible SKUs in Canada in Q4, including the #1 edible SKU nationwide.
International Growth, Especially Israel and Other Markets
Israel net revenue grew 52% year-over-year in Q4 (eighth consecutive quarter of record net revenue in Israel). International (outside Israel) net revenue up 68% year-over-year, led by Germany as shipment timing normalized.
Strategic M&A to Enter Netherlands Adult-Use Program
Entered definitive agreement to acquire CanAdelaar for upfront EUR 57.5 million (~$67.5M) plus contingent consideration tied to 0.5x normalized EBITDA for 2026 and 2027; CanAdelaar is the largest licensed producer in the Netherlands adult-use program and the acquisition is expected to be accretive and expand European footprint.
Strong Balance Sheet and Liquidity
Maintains no debt and $832 million in cash, cash equivalents and short-term investments (up $8 million from Q3 2025); additional financial assets include $21 million of loans receivable and $8 million of other investments. Positive operating cash flow before working capital changes of $18 million in the quarter.
Capital Discipline and Shareholder Returns
Active share repurchase program (declining share count in 2025) with $4 million of repurchases in Q4; modest CapEx ( ~$2 million in Q4) and guidance implying CapEx < $10 million for 2026.
Product Innovation Pipeline
Launched Spinach Puffers (all-in-one vape device) late in Q4 with broader Canadian roll-out in early 2026; continued focus on genetics, R&D and innovation in edibles, vapes and premium formats (Lord Jones).
TSE:CRON Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:CRON Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 26, 2026 | C$3.80 | C$3.67 | -3.42% |
Nov 06, 2025 | C$3.47 | C$3.47 | 0.00% |
Aug 07, 2025 | C$2.88 | C$3.11 | +7.99% |
May 08, 2025 | C$2.56 | C$2.78 | +8.59% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cronos Group (TSE:CRON) report earnings?
Cronos Group (TSE:CRON) is schdueled to report earning on May 12, 2026, Before Open (Confirmed).
What is Cronos Group (TSE:CRON) earnings time?
Cronos Group (TSE:CRON) earnings time is at May 12, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:CRON EPS forecast?
TSE:CRON EPS forecast for the fiscal quarter 2026 (Q1) is <0.01.
